argenx SE
IPOargenx | Homepage - Reaching Patients Through Immunology Innovation
Public · Amsterdam, Netherlands · Founded 2008 · $1.1B raised
- Headquarters
- Amsterdam
- Employees
- 501–1000
- Founded
- 2008
- Business Model
- B2B
- Website
- argenx.com
- Total Funding
- $1.1B
- Last Round
- $1.1B Growth EquityJul 2023
- Rounds
- 1
- Type
- Public
About
argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Founded in 2008, the company has built an antibody innovation ecosystem where pioneering scientists and antibody engineers work to accelerate the discovery of next-generation immunology medicines. Through its Immunology Innovation Program (IIP), argenx partners with leading academic institutions and biotechs to translate immunology breakthroughs into differentiated therapies, including its approved product VYVGART (efgartigimod alfa). The company operates across the United States, Europe, and Japan, combining deep immunology expertise with a co-creation model to deliver life-changing medicines for patients with conditions such as generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy.
Summary
argenx SE is a Biotech company based in Amsterdam, Netherlands, founded in 2008. It has raised $1.1B in total across 1 round, most recently a $1.1B Growth Equity round in Jul 2023. Investors include Forbion Capital Partners.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2023
Sign up to see all 3 rounds
IPO through Growth Equity — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/argenx-se"><img src="https://indexed.vc/api/badge/company/argenx-se" alt="argenx SE on Indexed.vc" width="260" height="76" /></a>